CorMedix

$8.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-1.50%) Today

$0.00 (0.00%) As of 12:18 PM UTC after-hours

Why Robinhood?

You can buy or sell CorMedix and other stocks, options, and ETFs commission-free!

About CRMD

CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ. The listed name for CRMD is CorMedix Inc.

CEO

Mohammed Khoso Baluch

Employees

Headquarters

Berkeley Heights, New Jersey

Founded

2006

Market Cap

279.78M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

560.46K

High Today

$8.83

Low Today

$8.39

Open Price

$8.75

Volume

599.11K

52 Week High

$9.42

52 Week Low

$2.16

Collections

CRMD Earnings

-$0.25

-$0.17

-$0.08

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 15, After Hours